Changes in specific domains of sexual function and sexual bother after radical prostatectomy
- PMID: 20184571
- DOI: 10.1111/j.1464-410X.2010.09231.x
Changes in specific domains of sexual function and sexual bother after radical prostatectomy
Abstract
Objective: To quantitatively assess the effect of radical prostatectomy (RP) on the specific domains that comprise overall sexual function (SF), focusing on the relationships among these domains and overall SF, and to identify predictors for recovery of SF over time, as a decline in SF and sexual bother (SB) are known potential complications of treatment for prostate cancer.
Patients and methods: Within the Cancer of the Prostate Strategic Urologic Research Endeavor database, we identified men diagnosed between 1995 and 2001 with localized prostate cancer treated with RP. SF and SB outcomes, measured using the University of California Los Angeles Prostate Cancer Index, were assessed at 6-month intervals for 4 years after RP.
Results: In all, 620 men met the study criteria; at 6 months after RP, overall and all the specific domains of SF declined, with improvement in most specific domains by 2 years after RP. The greatest declines were in the ability to achieve erections, high-quality erections, and frequent erections; these domains were also most strongly correlated with overall SF. Sexual desire was relatively preserved, and there was a weak correlation between overall SF and sexual desire after RP, when there was the greatest discrepancy between sexual desire and other domains of function. SB showed continued improvement over time to 4 years but was not well correlated with any measurements of SF assessed. Younger age, college education, sexual aid and medication use, the absence of comorbid conditions, and nerve-sparing surgery were predictive of significant recovery of function in several specific domains of SF.
Conclusions: RP affects specific domains of SF to differing degrees. Compromised erectile function is most commonly reported among these specific domains and seems to play a more dominant role in determining overall SF, but notably none of the domains of function were closely linked to SB. Because education is protective in the perception of bother, appropriate counselling and the setting of expectations for outcomes in overall and specific domains of SF might lead to improved quality of life after treatment for prostate cancer.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.
Similar articles
-
Quality of life after radical prostatectomy in Japanese men: 2 year longitudinal study.Jpn J Clin Oncol. 2005 Sep;35(9):551-8. doi: 10.1093/jjco/hyi145. Epub 2005 Sep 1. Jpn J Clin Oncol. 2005. PMID: 16141296
-
Life after radical prostatectomy: a longitudinal study.J Urol. 2001 Aug;166(2):587-92. J Urol. 2001. PMID: 11458073
-
Health related quality of life outcomes after radical prostatectomy: attention to study design and the patient-based importance of single-surgeon studies.Urol Oncol. 2006 Jan-Feb;24(1):28-32. doi: 10.1016/j.urolonc.2005.05.009. Urol Oncol. 2006. PMID: 16414489
-
Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function.Eur Urol. 2012 Aug;62(2):273-86. doi: 10.1016/j.eururo.2012.04.047. Epub 2012 May 3. Eur Urol. 2012. PMID: 22575910 Review.
-
Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control--a literature review.Urology. 2010 Nov;76(5):1194-8. doi: 10.1016/j.urology.2010.03.096. Urology. 2010. PMID: 20888624 Review.
Cited by
-
Unexpected Long-term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-reported Outcomes Following Radical Prostatectomy.Eur Urol. 2015 Nov;68(5):899-905. doi: 10.1016/j.eururo.2015.07.074. Epub 2015 Aug 17. Eur Urol. 2015. PMID: 26293181 Free PMC article.
-
Role of regenerative therapies on erectile dysfunction after radical prostatectomy.Int J Impot Res. 2021 May;33(4):488-496. doi: 10.1038/s41443-020-00406-3. Epub 2021 Jan 15. Int J Impot Res. 2021. PMID: 33452520 Review.
-
Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.J Natl Cancer Inst. 2014 Jul 8;106(7):dju132. doi: 10.1093/jnci/dju132. Print 2014 Jul. J Natl Cancer Inst. 2014. PMID: 25006192 Free PMC article.
-
Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?BJU Int. 2012 May;109(10):1520-4. doi: 10.1111/j.1464-410X.2011.10605.x. Epub 2011 Oct 14. BJU Int. 2012. PMID: 21999368 Free PMC article.
-
Prevalence and predicting factors for commonly neglected sexual side effects to brachytherapy for prostate cancer: a cross-sectional observational study.Sex Med. 2023 Dec 6;11(6):qfad064. doi: 10.1093/sexmed/qfad064. eCollection 2023 Dec. Sex Med. 2023. PMID: 38074492 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous